Day: August 5, 2020

WATERLOO, Ontario, Aug. 05, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (TSX: DSG) (Nasdaq:DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its second-quarter fiscal 2021 financial results after market close on Wednesday, September 9, 2020.Members of Descartes’ executive management team will host a conference call to discuss the company’s financial results at 5:00 p.m. ET on Wednesday, September 9. Designated numbers are +1 888 465-5079 for North America and +1 416 216-4169 for international, using Passcode 5773 518#.The company will simultaneously conduct an audio webcast on the Descartes website at www.descartes.com/descartes/investor-relations. Phone conference dial-in or webcast log-in is required approximately 10 minutes beforehand.A digital replay of the...

GONZALES, La., Aug. 05, 2020 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (the “Company”) (NASDAQ-CM: CRWS) today announced that it intends to release the results of its operations for the first quarter of fiscal year 2021 before the market opens on Wednesday, August 12, 2020.  E. Randall Chestnut, Chairman, President and Chief Executive Officer, and Olivia W. Elliott, Vice President and Chief Financial Officer, will host a teleconference at 1:00 p.m. Central Daylight Time on that day to discuss the Company’s results and answer appropriate questions.Interested individuals may join the teleconference by dialing (844) 861-5504. Please ask to be joined into the Crown Crafts, Inc. call.  The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com.  The financial information to be discussed...

 In the second quarter the Company was granted approval to market its CGuard™ MicroNet stent in Brazil and completed an $11.5 million capital raise; reported outstanding results in studies treating patients with the CGuard™ MicroNET stentManagement to host investor conference call today, August 5, 2020 at 8:30am ETTEL AVIV, Israel, Aug. 05, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the second quarter ended June 30, 2020.Second Quarter 2020 and recent highlights:Received approval from the Brazilian registration authority (ANVISA), to market the CGuard™ MicroNet®- covered stent, effectively clearing it for sale and distribution...

CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that management will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 12, 2020 at 10:20 a.m. ET.A live webcast of the company presentation will be available in the investor section of the company’s website at www.generationbio.com. The webcast will be archived for 60 days following the presentation.About Generation BioGeneration Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary, high-capacity DNA...

Second Quarter GAAP Loss of $10 Million or $0.14 Per Share Including Anticipated Acquisition, Integration and Financing Costs; Adjusted Earnings Per Share of $0.13Adjusted EBITDA Totaled $59 Million, Highlighting Positive Operational and Cost Performance While Facing COVID-19 Headwinds, as Well as Timing of Expenditures and Acquisition Contributions Net Cash Provided by Operating Activities of $33 Million in Q2; Free Cash Flow Totaled $18 Million Driven by Actions to Lower Capital Spending as Well as Working Capital Initiatives Company Net Leverage Ratio of 3.9x and Liquidity Position Exceeded $390 Million at Quarter-End Business Continuity Actions In Response to COVID-19 Driving Significant Cost Reductions;  Company Remains Committed to Lower Capital Spending and Positive Free Cash FlowCAMP HILL, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) —...

ROCKFORD, Mich., Aug. 05, 2020 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW) today reported  financial results for the second quarter ended June 27, 2020, that significantly exceeded its expectations across every key financial metric and provided an update on initiatives implemented to navigate the COVID-19 pandemic.“The Company’s second quarter results were much stronger than expected, despite the negative impact of unprecedented global market conditions and significant retail store closures for much of the time period,” said Blake W. Krueger, Wolverine Worldwide’s Chairman, Chief Executive Officer and President.  “Our brands excelled online, with nearly triple-digit owned eCommerce revenue growth, benefiting from strength in key product categories that are resonating with consumers and the digital capabilities...

Heidelberg, Germany, August 5, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointments of Dr. Annalisa Jenkins and Mr. Harry Welten to its Supervisory Board.  Both these appointments were approved during the Annual General Meeting of Shareholders which took place on August 4, 2020.“Affimed is pleased to welcome Annalisa and Harry, both highly experienced professionals in their respective fields, to the Supervisory Board” said Dr. Thomas Hecht, Chairman of Affimed’s Supervisory Board. “Annalisa is a visionary leader who knows how to translate science from bench to bedside.  Harry is an accomplished financial executive who is well suited to help drive value-creating strategies for the company.  Together, these new...